Back to Isotope Catalog
R-11063

Quetiapine.fumarate (d8)

Stable isotope standard for analytical research and method development.

Module Type
Stable Isotope Standards
Category
Drugs & TDM
CAS
1185247-12-4
Unlabeled CAS
1435938-24-1
PubChem CID
71751922
Molecular Formula
C25H21D8N3O6S
Molecular Weight
507.6
AI Isotope Property & Application AnalysisShow

Isotope Summary

Labels
D8
Labeled atoms
8
Isotope positions
Confirmed in structure
Calculation reliability
High, based on explicit isotope structure

Mass & MS Parameters

Unlabeled exact mass
898.444883 Da
Labeled exact mass
507.227921 Da
Exact mass shift
-391.216962 Da
Nominal mass shift
-391
Ionm/zStatus
[M+H]+508.235197Theoretical
[M+Na]+530.217139Theoretical
[M+NH4]+525.261744Theoretical
[M-H]-506.220644Theoretical

Label Stability

Overall
Moderate risk
Calculation reliability
Medium, some information should be confirmed
  • Carbon-bound deuterium is evaluated by local chemical environment; isotope effects should still be checked experimentally.

Internal Standard Suitability

Rating
Medium
Chromatographic similarity
Possible isotope effect
Natural isotope overlap
Low
  • Exact mass separation is -391.216962 Da; MS channel separation should be verified in the final method.
  • A parent structure was available or matched for comparison.
  • Overall suitability: Medium.

Recommended Applications

LC-MS/MS Quantitative Internal Standard
Recommended

LC-MS/MS Quantitative Internal Standard is classified as Recommended based on isotope mapping, mass separation, and label-stability rules.

Isotope Dilution Mass Spectrometry
Recommended

Isotope Dilution Mass Spectrometry is classified as Recommended based on isotope mapping, mass separation, and label-stability rules.

GC-MS Internal Standard
Possible

GC-MS Internal Standard is classified as Possible based on isotope mapping, mass separation, and label-stability rules.

Clinical Mass Spectrometry
Possible

Clinical Mass Spectrometry is classified as Possible based on isotope mapping, mass separation, and label-stability rules.

Bioanalytical Method Development
Recommended

Bioanalytical Method Development is classified as Recommended based on isotope mapping, mass separation, and label-stability rules.

AI Interpretation

This analysis is based on isotope-aware structure data. The compound contains D8, with an exact mass shift of -391.216962 Da. Label stability is assessed as Moderate risk, and internal-standard suitability is Medium. These results support analytical method development and require experimental validation.

AI-assisted analytical guidance is intended for method-development support. Actual isotope stability, chromatographic behavior, fragmentation and MRM transitions should be experimentally validated.